{"id":"https://openalex.org/W4243023366","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps9107","title":"A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated \u201cT790M undetectable or unknown\u201d non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study).","display_name":"A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated \u201cT790M undetectable or unknown\u201d non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study).","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W4243023366","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps9107"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.tps9107","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps9107","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps9107","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047170696","display_name":"Hector Jos\u00e8 Soto Parra","orcid":"https://orcid.org/0000-0001-7966-4472","observed_orcids":["https://orcid.org/0000-0001-7966-4472"]},"institutions":[{"id":"https://openalex.org/I4210129599","display_name":"Policlinico Universitario di Catania","ror":"https://ror.org/033xwx807","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210129599"]},{"id":"https://openalex.org/I4210160210","display_name":"Azienda Ospedaliero Universitaria Policlinico \"G.Rodolico - San Marco\"","ror":"https://ror.org/051tt6c85","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210160210"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Hector J. Soto Parra","raw_affiliation_strings":["Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;","institution_ids":["https://openalex.org/I4210129599","https://openalex.org/I4210160210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103688810","display_name":"Laura Noto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129599","display_name":"Policlinico Universitario di Catania","ror":"https://ror.org/033xwx807","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210129599"]},{"id":"https://openalex.org/I4210160210","display_name":"Azienda Ospedaliero Universitaria Policlinico \"G.Rodolico - San Marco\"","ror":"https://ror.org/051tt6c85","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210160210"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Noto","raw_affiliation_strings":["Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;","institution_ids":["https://openalex.org/I4210129599","https://openalex.org/I4210160210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021158045","display_name":"Domenico Galetta","orcid":"https://orcid.org/0000-0002-4878-5906","observed_orcids":["https://orcid.org/0000-0002-4878-5906"]},"institutions":[{"id":"https://openalex.org/I4210131058","display_name":"Istituto Tumori Bari","ror":"https://ror.org/03jxkz251","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210099368","https://openalex.org/I4210117053","https://openalex.org/I4210131058","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Domenico Galetta","raw_affiliation_strings":["Medical Oncology Department, Clinical Cancer Center Giovanni Paolo II, Bari, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Clinical Cancer Center Giovanni Paolo II, Bari, Italy;","institution_ids":["https://openalex.org/I4210131058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048720703","display_name":"Francesco Ferra\u00f9","orcid":"https://orcid.org/0000-0002-7472-6598","observed_orcids":["https://orcid.org/0000-0002-7472-6598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Ferra\u00fa","raw_affiliation_strings":["Medical Oncology Department, Ospedale S Vincenzo, Taormina, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Ospedale S Vincenzo, Taormina, Italy;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013748999","display_name":"Vittorio Gebbia","orcid":"https://orcid.org/0000-0001-8848-5951","observed_orcids":["https://orcid.org/0000-0001-8848-5951"]},"institutions":[{"id":"https://openalex.org/I4210163675","display_name":"La Maddalena","ror":"https://ror.org/04st1y556","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210163675"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vittorio Gebbia","raw_affiliation_strings":["Medical Oncology Unit, La Maddalena Clinic for Cancer, Palermo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, La Maddalena Clinic for Cancer, Palermo, Italy;","institution_ids":["https://openalex.org/I4210163675"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077467836","display_name":"Pierfrancesco Tassone","orcid":"https://orcid.org/0000-0002-8298-6787","observed_orcids":["https://orcid.org/0000-0002-8298-6787"]},"institutions":[{"id":"https://openalex.org/I36443711","display_name":"Magna Graecia University","ror":"https://ror.org/0530bdk91","country_code":"IT","type":"education","lineage":["https://openalex.org/I36443711"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pierfrancesco Tassone","raw_affiliation_strings":["Section of Medical Oncology, University of Catanzaro School of Medicine, Catanzaro, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Medical Oncology, University of Catanzaro School of Medicine, Catanzaro, Italy;","institution_ids":["https://openalex.org/I36443711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075338390","display_name":"Francesco Verderame","orcid":"https://orcid.org/0000-0001-5746-2845","observed_orcids":["https://orcid.org/0000-0001-5746-2845"]},"institutions":[{"id":"https://openalex.org/I4210099059","display_name":"Ospedale Vincenzo Cervello","ror":"https://ror.org/00twmyj12","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210099059"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Verderame","raw_affiliation_strings":["Cervello Hospital, Palermo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cervello Hospital, Palermo, Italy;","institution_ids":["https://openalex.org/I4210099059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080188224","display_name":"Marco Maria Aiello","orcid":"https://orcid.org/0000-0002-3386-9189","observed_orcids":["https://orcid.org/0000-0002-3386-9189"]},"institutions":[{"id":"https://openalex.org/I4210129599","display_name":"Policlinico Universitario di Catania","ror":"https://ror.org/033xwx807","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210129599"]},{"id":"https://openalex.org/I4210160210","display_name":"Azienda Ospedaliero Universitaria Policlinico \"G.Rodolico - San Marco\"","ror":"https://ror.org/051tt6c85","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210160210"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco M. Aiello","raw_affiliation_strings":["Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;","institution_ids":["https://openalex.org/I4210129599","https://openalex.org/I4210160210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113664074","display_name":"Fiorenza Latteri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129599","display_name":"Policlinico Universitario di Catania","ror":"https://ror.org/033xwx807","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210129599"]},{"id":"https://openalex.org/I4210160210","display_name":"Azienda Ospedaliero Universitaria Policlinico \"G.Rodolico - San Marco\"","ror":"https://ror.org/051tt6c85","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210160210"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fiorenza Latteri","raw_affiliation_strings":["Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy;","institution_ids":["https://openalex.org/I4210129599","https://openalex.org/I4210160210"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001428569","display_name":"Silvia Novello","orcid":"https://orcid.org/0000-0001-7653-9748","observed_orcids":["https://orcid.org/0000-0001-7653-9748"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Novello","raw_affiliation_strings":["Department of Oncology, University of Turin, Orbassano, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University of Turin, Orbassano, Italy;","institution_ids":["https://openalex.org/I55143463"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"TPS9107","last_page":"TPS9107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.9570000171661377},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.652999997138977},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8980000019073486},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.8500000238418579},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8190000057220459},{"id":"https://openalex.org/keywords/locally-advanced-or-metastatic-nsclc","display_name":"locally advanced or metastatic NSCLC","score":0.7850000262260437},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8320000171661377},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9309999942779541},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9295961856842041},{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.9035291075706482},{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.7940378189086914},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5766614079475403},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5589275360107422},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5329049229621887},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.513114333152771},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4815252423286438},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4665403664112091},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.46315306425094604},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.43996164202690125},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3565954566001892},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.34898242354393005},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.2524380087852478},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.20970526337623596}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.tps9107","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps9107","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps9107","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2892158844","https://openalex.org/W2569056264","https://openalex.org/W2570995666","https://openalex.org/W4388655140","https://openalex.org/W2767868796","https://openalex.org/W3134649710","https://openalex.org/W2761614799","https://openalex.org/W2761932957","https://openalex.org/W2947055267","https://openalex.org/W2612623181"],"abstract_inverted_index":{"TPS9107":[0],"Background:":[1],"Osimertinib":[2],"(OSI),":[3],"is":[4,108,138,153,200,204,217,232,297,319],"an":[5,42],"oral,":[6],"potent,":[7],"irreversible":[8],"inhibitor":[9],"of":[10,26,44,95,104,113,168,276,286,290,309,312],"both":[11],"epidermal":[12],"growth":[13],"factor":[14],"receptor":[15],"(EGFR)":[16],"sensitizing":[17,87],"and":[18,131,288,304],"resistance":[19,316],"mutations":[20],"(T790M)":[21],"indicated":[22],"for":[23,163,180,209,273],"the":[24,35,85,105,111,156,166,228,242,261,293],"treatment":[25],"pts":[27,211,246,269],"with":[28,41,50,77,185],"advanced":[29],"EGFR":[30,64,86,116,129],"T790M":[31,51,118,149,164],"mutation-positive":[32],"NSCLC.":[33],"In":[34,241],"AURA":[36],"study,":[37],"OSI":[38,114,186],"was":[39,66],"associated":[40],"ORR":[43,218],"21%":[45],"(13/61)":[46],"among":[47],"all":[48],"patients":[49,122],"negative":[52],"mutation.":[53],"Response":[54],"rate":[55,231,285,296],"broken":[56],"down":[57],"by":[58,92,155],"immediate":[59,62],"versus":[60,70],"no":[61,205],"prior":[63],"TKI":[65,130],"11%":[67],"(4/36":[68],"pts)":[69],"36%":[71],"(9/25)":[72],"respectively.":[73],"This":[74,278],"better":[75],"activity":[76],"deferred":[78],"OSI,":[79],"drug":[80],"able":[81],"to":[82,220,317],"inhibit":[83],"also":[84],"mutations,":[88],"could":[89],"be":[90,235,248,264,271],"explained":[91],"a":[93,127,132,139,238,274,281,310],"selection":[94],"sensitive":[96],"tumor":[97,160,174,178],"cells":[98],"during":[99],"chemotherapy":[100],"(re-challenge":[101],"strategy).":[102],"Aim":[103],"current":[106],"study":[107,137,262],"prospective":[109,140],"evaluate":[110],"efficacy":[112],"in":[115,257,315],"mutated,":[117],"\u201cundetectable":[119,150],"or":[120,151,171,176,194,254],"unknown\u201d":[121],"as":[123,202],"third-line":[124],"therapy":[125,208],"after":[126,212],"first-line":[128],"subsequent":[133],"chemotherapy.":[134,213],"Methods:":[135],"OSIRIS":[136],"single-arm,":[141],"phase":[142],"2,":[143],"open":[144],"label,":[145],"italian":[146],"multicenter":[147],"study.":[148],"unknown\"":[152],"defined":[154],"following":[157],"conditions:":[158],"inconclusive/negative":[159],"test":[161],"result":[162],"at":[165],"time":[167],"disease":[169,192],"progression":[170,193],"medical":[172],"inaccessible/contraindications/declined":[173],"biopsy":[175],"insufficient":[177],"tissue":[179],"testing.":[181],"Pts":[182],"are":[183,252,301],"treated":[184],"80":[187],"mg":[188],"once":[189],"daily":[190],"until":[191],"unacceptable":[195],"toxicity.":[196],"The":[197,214,224],"single-arm":[198],"design":[199,279],"appropriate,":[201],"there":[203,251],"accepted":[206],"standard":[207],"these":[210,258],"primary":[215],"endpoint":[216],"according":[219],"RECIST":[221],"version":[222],"1.1.":[223],"null":[225],"hypothesis":[226],"that":[227],"true":[229,294],"response":[230,295],"9%":[233],"will":[234,247,263,270],"tested":[236],"against":[237],"one-sided":[239],"alternative.":[240],"first":[243],"stage,":[244],"32":[245,259],"accrued.":[249],"If":[250],"3":[253],"fewer":[255],"responses":[256],"pts,":[260],"stopped.":[265],"Otherwise,":[266],"49":[267],"additional":[268],"accrued":[272],"total":[275],"81.":[277],"yields":[280],"type":[282],"I":[283],"error":[284],"0.05":[287],"power":[289],"80%":[291],"when":[292],"19%.":[298],"Secondary":[299],"endpoints":[300],"PFS,":[302],"OS":[303],"safety.":[305],"Exploratory:":[306],"mutational":[307],"analysis":[308],"panel":[311],"genes":[313],"involved":[314],"EGFR-TKIs":[318],"planned.":[320],"Clinical":[321],"trial":[322],"information:":[323],"2016-002555-17.":[324]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2022-05-12T00:00:00"}